New Vernon Capital Holdings II’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$398K	Sell	7,198 -340,897	-98%	-$18.8M	0.19%	31
2025 Q1	$7.2M	Buy	348,095 +345,034	+11,272%	+$7.13M	0.16%	40
2024 Q4	$118K	Buy	+3,061	New	+$118K	0.08%	63